We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
25 hedge funds and large institutions have $108M invested in Enzymotec Ltd in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
26% less funds holding
Funds holding: 34 → 25 (-9)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
43% less capital invested
Capital invested by funds: $187M → $108M (-$79.7M)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
25
Holders Change
-9
Holders Change %
-26.47%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VAM
Visium Asset Management
New York
|
+$16.1M |
| 2 |
D.E. Shaw & Co
New York
|
+$5.1M |
| 3 |
MCM
Matterhorn Capital Management
San Antonio,
Texas
|
+$2.25M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$977K |
Top Sellers
| 1 |
AP
Alydar Partners
Boston,
Massachusetts
|
-$6.86M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.81M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$4.77M |
| 4 |
PA
Perceptive Advisors
New York
|
-$4.72M |
| 5 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$4.37M |
